• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Investing Is it too late to invest in the Biotech stocks?
Investing

Is it too late to invest in the Biotech stocks?

by November 22, 2022
by November 22, 2022 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

“IBB” – the iShares Biotechnology ETF has already recovered about 30% over the past five months but Jefferies’ Michael Yee is convinced it still has more room to the upside.

Yee’s bull case for the biotech stock

Yee sees several catalysts that could potentially push these stocks further up in the coming months.

To begin with, biotech had a strong third quarter and more importantly, notable names in this space raised their guidance as well. That signals continued strength. Yee is also bullish because:

The visibility on cancer drugs and new diabetes drugs and new obesity drugs is pretty [clear] over the next twelve months. So, we think it’s been a great place to be, but we still think there’s more to go.

On top of that, inflation seems to be coming down as Invezz reported here. In response, if the Fed chooses to “pause”, it will create a better macroeconomic environment for the biotech stocks as well.

Biotech stocks are still not expensive

Versus the start of 2022, IBB is still down more than 10%.

And that makes up for another reason why Yee recommends investing in this exchange-traded fund. On CNBC’s “Power Lunch”, he said:

These stocks were super cheap. Even though they’re up 30% to 40% off the bottom, they’re still not expensive. So, we still think there’s room to go.

In terms of individual names, he’s particularly bullish on the likes of Gilead Sciences Inc (NASDAQ: GILD) that’s still trading well below the average of its price-to-earnings ratio for the past five years.

The post Is it too late to invest in the Biotech stocks? appeared first on Invezz.

You Might Also Like
  • Oorbit partners LG to bring metaverse games to smart TVs
  • 40+ Apple statistics 2022: AAPL stock, revenue and performance
  • SteadyOptions 2022 – Year In Review
  • Microsoft to invest another $10 billion in company behind ChatGPT
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Walgreens stock price forecast: Cowen sees another 30% upside
next post
Is corrupt Glencore a good buy after rising by 40% YTD?

You may also like

Options Theta Explained: Price Sensitivity To Time

April 22, 2023

A preview of the December NFP report and its implications...

November 30, 2022

Why Alibaba stock is rising and the next price target

January 9, 2023

WisdomTree unveils nine new blockchain-enabled funds

December 14, 2022

CAC 40 index forecast after S&P cuts France’s outlook to...

December 4, 2022

Bernstein analyst reacts to TSMC boosting investment in the U.S.

December 6, 2022

Lululemon stock is down 13% today: buy the dip?

December 9, 2022

The UK Plans to Do Away With Ring-Fencing Regulations in...

November 30, 2022

Here’s how Adobe did in its fourth financial quarter

December 15, 2022

Top 3 monthly dividend stocks to boost your income stream

November 25, 2022

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • OpenAI tops 3 million paying business users, launches new features for workplace

      June 5, 2025
    • Why ADX Can Mislead You — And How to Avoid It

      June 4, 2025
    • S&P 500 on the Verge of 6,000: What’s at Stake?

      June 4, 2025
    • Nationwide coordinated retail crime crackdown results in hundreds of arrests, authorities say

      June 4, 2025
    • Strategic Chaos or Tactical Goldmine? What QQQ’s Chart is Whispering Right Now

      June 4, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,783 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,488 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,469 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,449 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,327 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,117)
    • Investing (538)
    • Stock (2,590)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • OpenAI tops 3 million paying business users, launches new features...

      June 5, 2025
    • Why ADX Can Mislead You — And How to Avoid...

      June 4, 2025
    • S&P 500 on the Verge of 6,000: What’s at Stake?

      June 4, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,117)
    • Investing (538)
    • Stock (2,590)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Metropolitan Bank Holding (MCB) exits the...

    January 9, 2023

    Stock market soars as inflation comes...

    December 13, 2022

    3 takeaways after Wednesday’s FOMC Minutes...

    January 5, 2023
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here